by clearskymd | Feb 7, 2023 | Company News
ClearSky Medical Diagnostics has been selected as a UK Life Sciences Innovator 2023 by the UK’s Department for International Trade (DIT). After a rigorous selection process, we are one of 57 companies chosen to showcase the best of UK innovation at global life...
by clearskymd | Dec 2, 2022 | Company News
ClearSky attended MEDICA 2022 in Düsseldorf, Germany as part of the UK Healthcare Pavilion, supported by the Department for International Trade (DIT). The event, in November 2022, is one of the world’s largest medical trade fair held annually for medical...
by clearskymd | Sep 1, 2022 | Company News
The ClearSky Medical Diagnostics team will be attending the International Parkinson and Movement Disorder Society (MDS) Congress in Spain this September. After two years of virtual events, the 2022 MDS Congress returns as a hybrid event – taking place virtually...
by clearskymd | Jun 10, 2022 | Company News
ClearSky’s co-founder Professor Stephen Smith discusses disruptive healthcare technologies in neurodegenerative diseases in the latest SCOR Innovation Podcast. The SCOR Innovation Podcast channel sheds light on evolving consumer needs in Life & Health...
by clearskymd | Apr 13, 2022 | Company News
ClearSky Medical Diagnostics recently attended and exhibited at the 35th Global Conference of Alzheimer’s Disease International in June 2022. The hybrid conference, hosted online and in-person at The Kia Oval in London, took place from 9 to 11 June 2022 with the...
by clearskymd | Mar 24, 2022 | Company News
ClearSky Medical Diagnostics has developed an intelligent medical device that can objectively diagnose mild cognitive impairment (MCI), a condition often suggested as an early stage of dementia. It is estimated that between five and 20 per cent of people aged over 65...
Recent Comments